ALB and Cowden syndrome 1: However, albumin supplementation was not associated with the risk of 30-day all-cause mortality in CS patients (74% vs. 60%; log-rank p = 0.729; HR = 1.095; 95% CI 0.635–1.889; p = 0.743) (Figure 5).